resource source identifier antibodies rabbit polyclonal anti tslp proteintech (Proteintech)
94
Structured Review
Proteintech
resource source identifier antibodies rabbit polyclonal anti tslp proteintech
Resource Source Identifier Antibodies Rabbit Polyclonal Anti Tslp Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/resource+source+identifier+antibodies+rabbit+polyclonal+anti+tslp+proteintech/TSLP+Antibody/pm39383861-549-2-9
Average 94 stars, based on 21 article reviews
Resource Source Identifier Antibodies Rabbit Polyclonal Anti Tslp Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/resource+source+identifier+antibodies+rabbit+polyclonal+anti+tslp+proteintech/TSLP+Antibody/pm39383861-549-2-9
Average 94 stars, based on 21 article reviews
resource source identifier antibodies rabbit polyclonal anti tslp proteintech - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Recombinant:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Real-time Polymerase Chain Reaction:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Luciferase:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Reporter Gene Assay:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Transfection:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Quantitative RT-PCR:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Software:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Cell Culture:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. Modification:Article Title: A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Article Snippet: In brief Yin et al. develop a dual-input programmed CRISPR-dCas9-based gene modulation biocomputer (REPACRISPR) for conditional endogenous gene transcriptional regulation and mathematical models to predict doseresponsive endogenous gene transcription.. This work expands the field of controllable epigenetic remodeling and provides a logic control method for gene function research and gene therapy. |